BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35030977)

  • 1. Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway.
    Deng G; Luo Y; Zhang Y; Zhang J; He Z
    Bioengineered; 2022 Feb; 13(2):2194-2206. PubMed ID: 35030977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Li W; Pang Y; Zhou Z; Liu S; Cheng K; Qin Q; Jia Y; Liu S
    EBioMedicine; 2018 Dec; 38():57-68. PubMed ID: 30391496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of EGFL8 regulates migration, invasion and apoptosis of hepatocellular carcinoma through activating Notch signaling pathway.
    Wu F; Zhang FY; Tan GQ; Chen WJ; Huang B; Yan L; Zhang HL; Chen S; Jiao Y; Wang BL
    BMC Cancer; 2021 Jun; 21(1):704. PubMed ID: 34130659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA.
    Ye Y; Yu F; Li Z; Xie Y; Yu X
    Bioengineered; 2021 Dec; 12(1):6144-6154. PubMed ID: 34486474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma.
    Son JA; Weon JH; Baek GO; Ahn HR; Choi JY; Yoon MG; Cho HJ; Cheong JY; Eun JW; Kim SS
    J Exp Clin Cancer Res; 2023 Oct; 42(1):288. PubMed ID: 37899451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-139-5p/ENAH Affects Progression of Hepatocellular Carcinoma Cells.
    Zhang Y; Li M; Qiu Y; Wu Y; Chen S; Ni B; Tang D; Deng Z; Hu Z
    Biochem Genet; 2022 Dec; 60(6):2106-2119. PubMed ID: 35254597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00261 suppresses cell proliferation, invasion and Notch signaling pathway in hepatocellular carcinoma.
    Zhang HF; Li W; Han YD
    Cancer Biomark; 2018 Feb; 21(3):575-582. PubMed ID: 29278875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPAA1 promotes the proliferation, invasion and migration of hepatocellular carcinoma cells by binding to RNA-binding protein SF3B4.
    Ge S; Zhang Q; Yang X
    Oncol Lett; 2022 May; 23(5):160. PubMed ID: 35399327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRSF3 Depletion Leads to an Increase in SF3B4 Expression in SNU-368 HCC Cells.
    Lee J; Seo G; Hur W; Yoon SK; Nam SW; Lee JH
    Anticancer Res; 2020 Apr; 40(4):2033-2042. PubMed ID: 32234894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOR1 promotes hepatocellular carcinoma cell proliferation and migration through modulating the Notch signaling pathway.
    You K; Sun P; Yue Z; Li J; Xiong W; Wang J
    Exp Cell Res; 2017 Mar; 352(2):375-381. PubMed ID: 28232113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J; Fan Z; Li J; Yang J; Liu X; Cheng J
    Bioengineered; 2021 Dec; 12(1):3566-3577. PubMed ID: 34281492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
    Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
    Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of protein O-fucosyltransferase 1 accelerates hepatocellular carcinoma progression via the Notch signaling pathway.
    Ma L; Dong P; Liu L; Gao Q; Duan M; Zhang S; Chen S; Xue R; Wang X
    Biochem Biophys Res Commun; 2016 Apr; 473(2):503-10. PubMed ID: 27003260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vacuolar protein sorting-associated protein 72 homolog (VPS72) binding to lysine acetyltransferase 5 (KAT5) promotes the proliferation, invasion and migration of hepatocellular carcinoma through regulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway.
    Chen T; Tu Y; Lv D; Lin K; Tang H; Huang W
    Bioengineered; 2022 Apr; 13(4):9197-9210. PubMed ID: 35383533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Copy Number of the Gene Encoding SF3B4 Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Iguchi T; Komatsu H; Masuda T; Nambara S; Kidogami S; Ogawa Y; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Maehara Y; Mimori K
    Anticancer Res; 2016 May; 36(5):2139-44. PubMed ID: 27127115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SF3B4 as an early-stage diagnostic marker and driver of hepatocellular carcinoma.
    Shen Q; Nam SW
    BMB Rep; 2018 Feb; 51(2):57-58. PubMed ID: 29397868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
    Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
    J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells.
    Zhang S; Yang Y; Liang Z; Duan W; Yang J; Yan J; Wang N; Feng W; Ding M; Nie Y; Jin Z
    PLoS One; 2013; 8(12):e83699. PubMed ID: 24386256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.